Japan recognizes Covaxin to facilitate travel between both countries

"The Government of Japan has included Bharat Biotech"s Covaxin in the list of recognised vaccines to further facilitate travel from India to Japan starting April 10, 2022," Bharat Biotech said in a tweet.

NewsBharati    08-Apr-2022 17:12:38 PM
Total Views |
New Delhi, April 8: Japan has included Bharat Biotech's Covaxin in the list of recognised vaccines, a move aimed at facilitating travel between the two countries, said the Indian Embassy in Japan.

Covaxin
 
Taking to Twitter, the Embassy wrote, "Government of Japan includes the indigenously developed and manufactured COVID-19 vaccine COVAXIN by Bharat Biotech of India, as one of the recognised vaccines for 1st and 2nd dose with effect from 10 April 2022 to further facilitate travel from India to Japan."
 
 
"The Government of Japan has included Bharat Biotech's Covaxin in the list of recognised vaccines to further facilitate travel from India to Japan starting April 10, 2022," Bharat Biotech said in a tweet.

Notably, PM Narendra Modi and his Japanese counterpart Fumio Kishida welcomed the Quad Leaders` Summits in March 2022 and September 2021 and renewed their commitment to delivering tangible outcomes on the Quad`s positive and constructive agenda, especially on COVID vaccines, critical and emerging technologies, climate action, infrastructure coordination, cybersecurity, space, and education.
 
 
They looked forward to advancing Quad cooperation through the next Quad Leaders` Summit in Japan in the coming months. In March, the two leaders reaffirmed the importance of collaborative projects between the two countries in the Indo-Pacific region and looked forward to expansion of such projects to ASEAN, Pacific island countries and others.

Japanese Prime Minister Fumio Kishida also used the opportunity to welcome India`s Indo-Pacific Oceans` Initiative (IPOI) launched by Prime Minister Narendra Modi in 2019.